Literature DB >> 1677718

Yeasts susceptibility testing.

J Dupouy-Camet, A Paugam, C Tourte-Schaefer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677718     DOI: 10.1016/0140-6736(91)90514-p

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Susceptibility of yeasts to fluconazole.

Authors:  M Scheven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

2.  Evaluation of five commercial antifungal susceptibility testing systems.

Authors:  A Druetta; A Freydiere; R Guinet; Y Gille
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

3.  Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.

Authors:  L Millon; A Manteaux; G Reboux; C Drobacheff; M Monod; T Barale; Y Michel-Briand
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

4.  Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis.

Authors:  P Y Chavanet; I Garry; N Charlier; D Caillot; J P Kisterman; M D'Athis; H Portier
Journal:  BMJ       Date:  1992-10-17

5.  The antifungal activities of some 6-[N-(halophenyl)amino]-7-chloro-5,8-quinolinediones against Candida species.

Authors:  C K Ryu; D H Kim
Journal:  Arch Pharm Res       Date:  1994-12       Impact factor: 4.946

6.  Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group.

Authors:  P Sandven; A Bjørneklett; A Maeland
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.